1. Volume 373, Issue 9666, Pages 811-820 (March 2009)
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial 
Dr David Sebag-Montefiore, FRCR, Richard J Stephens, Prof Robert Steele, MD, Prof John Monson, MD, Robert Grieve, FRCR, Subhash Khanna, FRCR, Prof Phil Quirke, FRCPath, Jean Couture, MD, Catherine de Metz, MD, Arthur Sun Myint, FRCR, Eric Bessell, FRCR, Gareth Griffiths, MSc, Lindsay C Thompson, MSc, Prof Mahesh Parmar, DPhil 
The Lancet 
Volume 373, Issue 9666, Pages (March 2009)
DOI: /S (09)
Copyright © 2009 Elsevier Ltd Terms and Conditions

2. Figure 1
Trial profile
CRT=chemoradiotherapy. CRM=circumferential resection margin. ITT=intention to treat.
The Lancet  , DOI: ( /S (09) )
Copyright © 2009 Elsevier Ltd Terms and Conditions

3. Figure 2
Proportion of patients with a confirmed local recurrence (A), disease-free survival (B), and overall survival (C)
The Lancet  , DOI: ( /S (09) )
Copyright © 2009 Elsevier Ltd Terms and Conditions

4. Figure 3
Summary of reduction in risk of local recurrence in phase III trials that have assessed short-course preoperative radiotherapy with 5 Gy per fraction
The Lancet  , DOI: ( /S (09) )
Copyright © 2009 Elsevier Ltd Terms and Conditions